Diabetic health

On this page:

• Adlyxine
• Entuzity Kwikpen^B
• Fiasp^B
• Tresiba (Flextouch)^B, Tresiba (Penfill)^B

Adlyxine

(new active substance)

Medical ingredient:

Lixisenatide

Indication:

Adlyxine is used along with diet and exercise to improve control of blood sugar levels in adults with type 2 diabetes.

For more information, see the Regulatory Decision Summary.

Entuzity Kwikpen^B

Medical ingredient:

Insulin Injection Human Biosynthetic

Indication:

Entuzity is a synthetic human insulin that is used to control high blood sugar in patients with diabetes mellitus who need more than 200 units of insulin in a day.

For more information, see the Regulatory Decision Summary.

Fiasp^B

Medical ingredient:

Insulin Aspart

Indication:

Fiasp is used in the treatment of patients with diabetes mellitus who require insulin for the control of high blood sugar.

For more information, see the Regulatory Decision Summary.

Tresiba (Flextouch)^B, Tresiba (Penfill)^B

(new active substance)

Medical ingredient:

Insulin Degludec

Indication:

Tresiba is a long-acting man-made insulin used to control high blood sugar in adults with diabetes mellitus.

For more information, see the Regulatory Decision Summary.

Health Canada approved two new generic drugs for diabetic health.

Admelog^B

Medical ingredient:

Insulin Lispro

Indication:

Admelog (insulin lispro injection), is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.

For more information, see the Regulatory Decision Summary.

Freestyle Libre Flash Glucose Monitoring System

(novel technology)

Indication:

A medical device used for measuring interstitial fluid glucose levels in adults aged 18 years and older who have at least 2 years of experience in self-managing their diabetes, and is intended to replace blood glucose testing in certain cases.

For more information,see the Regulatory Decision Summary.

Health Canada released three risk communications for diabetic health.